![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
EFFECTIVENESS AND TOLERABILITY OF DTG+3TC
IN CLINICAL PRACTICE: EVIDENCE IN PLHIV FROM REAL-WORLD DATA
|
|
|
Lee A. Evitt,1 Rahul Kumar,2 Rahul Dinesh Kamath,2 Diwakar Jha,2 Daniel Parks,3 Jean van Wyk,1 Annemiek de Ruiter1
1ViiV Healthcare, London, UK; 2GlaxoSmithKline Knowledge Centre, Gurgaon, India; 3GlaxoSmithKline, Upper Providence, PA, USA
![1002211](../images/100221/100221-3/1002211.gif)
![1002212](../images/100221/100221-3/1002212.gif)
![1002213](../images/100221/100221-3/1002213.gif)
![1002214](../images/100221/100221-3/1002214.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|